טוען...
Outcomes of Patients with Light Chain Amyloidosis who had Autologous Stem Cell Transplantation with Three or more Organs Involved.
BACKGROUND: Prior reports suggested that three or more organ involvement is a contraindication for autologous stem cell transplant (ASCT) in light chain amyloidosis (AL). Therefore, most centers limit transplantation to patients who have no more than two organs significantly involved. METHODS: We re...
שמור ב:
| הוצא לאור ב: | Biol Blood Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6698422/ https://ncbi.nlm.nih.gov/pubmed/31054986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.04.024 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|